饮食修改逆转了心力衰竭和保存的喷射分数的老鼠的透缩功能障碍
Myung Yoon Kim1, Isabelle Pellot1, Catherine Bresee2
1Smidt Heart Institute, Cedars-Sinai Medical Center, United States of America.
Journal of molecular and cellular cardiology plus
|June 5, 2023
概括
将达尔盐敏感大鼠从高盐饮食转换为正常盐饮食,逆转了心力衰竭与保留射出分数 (HFpEF) 症状. 饮食修改改善了心脏功能和存活率,证明了其对HFpEF的治疗潜力.
科学领域:
- 心脏病学 心脏病学
- 脏生理学 脏生理学
- 营养科学 营养科学
背景情况:
- 达尔盐敏感 (DSS) 老鼠吃高盐饮食会发展出心力衰竭与保存的喷射分数 (HFpEF).
- 高血压引起的炎症和心室纤维化是HFpEF发展的关键因素.
- 饮食盐摄入量显著影响心血管健康和疾病进展.
研究的目的:
- 调查饮食盐修改对DSS大鼠建立的HFpEF的影响.
- 为了确定从高盐饮食转换为普通盐饮食是否可以逆转HFpEF表型.
- 评估饮食改变对心脏功能,纤维化和存活率的影响.
主要方法:
- 雄性DSS大鼠被食高盐 (8%NaCl) 饮食以诱导HFpEF.
- 已确认腹功能障碍的老鼠被随机分为继续高盐或切换到正常盐 (0.3%NaCl) 饮食.
- 进行了心声学,跑步机运动测试和组织学分析 (马森三色谱).
主要成果:
- 饮食修改改善了透缩功能 (降低了E/E'比率) 并增加了运动能力.
- 在切换到正常盐饮食的老鼠中,肺堵塞 (肺/体重比) 减少了.
- 腹腔纤维化显著减少,与持续高盐饮食的老鼠相比,存活时间延长.
- 缩血压和心室缩保持不变;心律失常的诱导性和QTc间隔没有改变.
结论:
- 饮食盐的减少可以逆转DSS大鼠中已建立的HFpEF表型.
- 正常的盐饮食摄入减轻心脏纤维化,改善功能能力和生存率.
- 饮食修改为HFpEF提供了一个潜在的治疗策略,独立于血压控制.
相关概念视频
01:22Heart Failure Drugs: Diuretics
428
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
428
01:30Heart Failure V: Medical Management
16
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
16
01:29Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
470
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
470
01:22Heart Failure VI: Adjunct Therapies
17
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
17
01:28Mitral Regurgitation IV: Nursing Management
51
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
51